Shin, D.W.; Park, J.; Lee, J.-C.; Kim, J.; Kim, Y.H.; Hwang, J.-H.
Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers 2022, 14, 2476.
https://doi.org/10.3390/cancers14102476
AMA Style
Shin DW, Park J, Lee J-C, Kim J, Kim YH, Hwang J-H.
Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers. 2022; 14(10):2476.
https://doi.org/10.3390/cancers14102476
Chicago/Turabian Style
Shin, Dong Woo, Jaewon Park, Jong-Chan Lee, Jaihwan Kim, Young Hoon Kim, and Jin-Hyeok Hwang.
2022. "Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma" Cancers 14, no. 10: 2476.
https://doi.org/10.3390/cancers14102476
APA Style
Shin, D. W., Park, J., Lee, J. -C., Kim, J., Kim, Y. H., & Hwang, J. -H.
(2022). Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers, 14(10), 2476.
https://doi.org/10.3390/cancers14102476